These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3141936)

  • 1. Epoprostenol in patients with Raynaud's disease.
    Fitscha P; Kaliman J; Weidinger F; Sinzinger H; O'Grady J
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):23-7. PubMed ID: 3141936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged remission in Raynaud's phenomenon after prostacyclin infusion.
    Bellucci S; Kedra AW; Courmelle JM; Maclouf J; Boizard B; Dosquet-Bernard C; Tobelem G; Caen JP
    Scand J Rheumatol; 1986; 15(4):392-8. PubMed ID: 3547631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma 6 keto PGE1 alpha concentration in Raynaud's phenomenon.
    Kinney EL; Demers LM
    Prostaglandins Med; 1981 Nov; 7(5):389-93. PubMed ID: 6895673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dazoxiben, a thromboxane synthetase inhibitor, in Raynaud's phenomenon.
    Luderer JR; Nicholas GG; Neumyer MM; Riley DL; Vary JE; Garcia G; Schneck DW
    Clin Pharmacol Ther; 1984 Jul; 36(1):105-15. PubMed ID: 6428793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma eicosanoids, platelet function and cold sensitivity.
    Wilkinson D; Vowden P; Gilks L; Latif AB; Rajah SM; Kester RC
    Br J Surg; 1989 Apr; 76(4):401-5. PubMed ID: 2720355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of platelet function in patients with Raynaud's syndrome.
    Hutton RA; Mikhailidis DP; Bernstein RM; Jeremy JY; Hughes GR; Dandona P
    J Clin Pathol; 1984 Feb; 37(2):182-7. PubMed ID: 6229551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome. A double-blind controlled trial.
    Belch JJ; Newman P; Drury JK; McKenzie F; Capell H; Leiberman P; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):313-5. PubMed ID: 6130329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of Raynaud's syndrome with Iloprost, a chemically stable prostacyclin analogue.
    Yardumian DA; Isenberg DA; Rustin M; Belcher G; Snaith ML; Dowd PM; Machin SJ
    Br J Rheumatol; 1988 Jun; 27(3):220-6. PubMed ID: 2454140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dazoxiben, a thromboxane synthetase inhibitor on skin-blood flow following cold challenge in patients with Raynaud's phenomenon.
    Tindall H; Tooke JE; Menys VC; Martin MF; Davies JA
    Eur J Clin Invest; 1985 Feb; 15(1):20-3. PubMed ID: 3921380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled study of intravenous prostacyclin on hemodynamics in severe Raynaud's phenomenon: the acute vasodilatory effect is not sustained.
    Kingma K; Wollersheim H; Thien T
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):388-93. PubMed ID: 8583779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
    Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
    BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin.
    Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW
    Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2.
    Ylikorkala O; Mäkilä UM; Viinikka L
    Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Trial treatment of severe Raynaud's phenomenon with prostacyclin (PGI2)].
    Cabane J; Boue F; Godeau P; Lecompte T; Charpentier MC; Samama M; Nebout T
    Rev Med Interne; 1985 Dec; 6(5):581-9. PubMed ID: 3914023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An imbalance in plasma prostanoids in patients with Raynaud's phenomenon and pulmonary vasospasm.
    Sakamoto K; Houya I; Inoue K; Tanaka M; Suzuki T; Sakamoto Y; Matsuo H
    Eur Respir J; 1999 Jan; 13(1):137-44. PubMed ID: 10836338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise-induced increase in plasma arachidonic acid and thromboxane B2 in healthy men: effect of beta-adrenergic blockade.
    Laustiola K; Seppälä E; Nikkari T; Vapaatalo H
    J Cardiovasc Pharmacol; 1984; 6(3):449-54. PubMed ID: 6202971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the Use of Epoprostenol to Treat Raynaud's Phenomenon With or Without Digital Ulcers.
    Cruz JE; Ward A; Anthony S; Chang S; Bae HB; Hermes-DeSantis ER
    Ann Pharmacother; 2016 Dec; 50(12):1060-1067. PubMed ID: 27465880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels.
    Stampfer MJ; Jakubowski JA; Faigel D; Vaillancourt R; Deykin D
    Am J Clin Nutr; 1988 Apr; 47(4):700-6. PubMed ID: 3128100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura.
    Lee SH; Wainscoat JS; Zeitlin H; Bolton FG; Leaver HA; Seawright A; Preece JM
    Br Med J (Clin Res Ed); 1981 Nov; 283(6303):1351-2. PubMed ID: 6797537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the "vascular factor" on platelet and vascular arachidonic acid metabolism in man.
    Conte D; Romanelli F; Nordio M; Baldacci M; Isidori A
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):601-3. PubMed ID: 3935585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.